Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis

NCT01159769 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01159769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01159769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Lead sponsor
Alcon Research
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
August 31, 2010
Enrollment
215 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis